Navigation Links
DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
Date:5/29/2013

Chicago, IL (PRWEB) May 29, 2013

The birth control safety advocates at DrugRisks.com are announcing a new resource center for patients who have taken the contraceptives Yaz or Yasmin. The site contains warnings about the drugs’ alleged link to blood clots and compensation offered by Bayer for victims.

DrugRisks was created to give patients taking popular prescription drugs like Yaz and Yasmin the latest warnings, recalls, studies and legal news. With access to clear information, patients can discuss side effect concerns with their doctor and decide if they need legal advice.

The resource center contains studies from the British Medical Journal* and FDA** showing patients taking birth control pills containing drospirenone, like Yaz and Yasmin, may have an increased risk of developing blood clots.

With a growing number of patients filing a Yaz lawsuit alleging blood clot injuries, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

DrugRisks has also learned that the maker of Yaz and Yasmin, Bayer, has spent nearly $1 billion so far to settle around 4,800 claims alleging Yaz blood clots, and will continue to evaluate new claims for settlement on a case-by-case basis***.

Although a federal court recently opened up competition for Yaz from generics****, DrugRisks cautions patients that blood clots have been linked to the chemical drospirenone, which is used in both brand name and generic formulations.

Lawyers are still helping those affected file a claim. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugRisks Center or speak with a lawyer about their legal options.

Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions that patients should seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, side effects and litigation news related to Yaz or Yasmin, or to speak with a lawyer.

*BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
**FDA, 10/27/11, fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
***Bayer 2/28/13; annualreport2012.bayer.com/en/legal-risks.aspx
****Business Week, 4/16/13; businessweek.com/news/2013-04-16/bayer-patent-on-yaz-birth-control-pill-ruled-invalid

Read the full story at http://www.prweb.com/releases/DrugRisks-Yaz-Side/Effects-Center/prweb10777913.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
2. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
3. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
4. DrugRisks Update: Yaz Class Action Begins in Canada as Settlements Continue in U.S.
5. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
6. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
7. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
8. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
9. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
10. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
11. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... 18, 2017 , ... “Prompted By Love”: a love story thrown into doubt ... Nettles. Author Mary P. Nettles has devoted her life to ministry since the ... lifelong desire to write was, however, not fulfilled until 2014 when "The Color of ...
(Date:8/18/2017)... ... ... “Case #10-5411 Veterans Administration”: a personal account of corruption ... Administration” is the creation of published author, Carol Mulhern, single mother of two ... work at the Coatesville VAMC as a file clerk then later became the ...
(Date:8/17/2017)... ... August 17, 2017 , ... Shared leadership between ... extremely effective, very effective, or effective by 85% of respondents, according to the ... Insights Reports are based on surveys of the NEJM Catalyst Insights Council, a ...
(Date:8/17/2017)... ... August 17, 2017 , ... When Amy Cowperthwait left the ... took with her a dream to make nursing education more relevant and prepare aspiring ... skills were integrated into healthcare provider education. , “The human element was ...
(Date:8/17/2017)... ... August 17, 2017 , ... CARF ... three years for its residential drug and alcohol detox program. This accreditation decision ... and shows the organization’s substantial conformance to the CARF standards. , Behavioral health ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)...  AOTI Inc. announced today that its fully owned ... a New York City Office in Yonkers, New York ... Wound Oxygen (TWO 2 ) homecare therapy. This new East Coast ... Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical Equipment ... Advanced Oxygen Therapy ...
(Date:8/8/2017)... --   Second-quarter 2017 revenues ... per share from continuing operations ... percent to $110 million ... $161 million Second-quarter 2017 ... increased 8 percent to $0.93 ...
(Date:8/7/2017)...  Endo International plc (NASDAQ: ENDP ) ... all known U.S. mesh product liability claims and that ... remaining U.S. claims at reasonable values. Under the agreements, ... quarter of 2017 and continuing through the fourth quarter ... results, the Company intends to increase its mesh product ...
Breaking Medicine Technology: